Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-05-13 Sale |
2020-05-15 5:19 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Fundaro Paolo Director 10% Owner |
595,578 | $84.6 | $50,385,899 | 5,519,433 (Indirect Direct) |
View |
2020-05-13 Sale |
2020-05-15 4:55 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Micheli Francesco 10% Owner |
595,578 | $84.6 | $50,385,899 | 5,500,000 (Indirect) |
View |
2020-05-13 Sale |
2020-05-15 4:46 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Genextra S.p.A. 10% Owner |
595,578 | $84.6 | $50,385,899 | 5,500,000 (Direct) |
View |
2020-04-27 Sale |
2020-04-29 7:00 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development |
181 | $85.95 | $15,557 | 17,140 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2020-05-28 Option Award |
2020-06-01 7:07 pm |
N/A 2030-05-28 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | AKKARAJU SRINIVAS Director |
4,561 | $0 | 429,775 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 7:05 pm |
N/A 2030-05-28 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Benatti Luca Director |
4,561 | $0 | 13,687 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 7:05 pm |
N/A 2030-05-28 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | BRADBURY DANIEL Director |
4,561 | $0 | 19,560 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 7:04 pm |
N/A 2030-05-28 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Gottesdiener Keith Michael Director |
4,561 | $0 | 12,919 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 7:03 pm |
N/A 2030-05-28 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Miller-Rich Nancy Director |
4,561 | $0 | 10,504 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 7:02 pm |
N/A 2030-05-28 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | SANTINI GINO Director |
4,561 | $0 | 11,845 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 7:01 pm |
N/A 2030-05-28 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | SBLENDORIO GLENN Director |
4,561 | $0 | 11,647 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 7:01 pm |
N/A 2030-05-28 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | WELCH DANIEL G Director |
4,561 | $0 | 11,026 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 7:00 pm |
N/A 2030-05-28 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Fundaro Paolo Director 10% Owner |
4,561 | $0 | 5,523,994 (Direct) |
View |
2020-05-27 Tax Withholding |
2020-05-29 7:00 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Weyer Christian EVP, Research & Development |
357 | $74.43 | 16,783 (Direct) |
View |
2020-05-23 Tax Withholding |
2020-05-27 7:00 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Durso Jerome Benedict Chief Operating Officer |
319 | $80.51 | 40,000 (Direct) |
View |
2020-05-13 Tax Withholding |
2020-05-14 7:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Sullivan Ryan T General Counsel and Secretary |
493 | $85.08 | 25,694 (Direct) |
View |
2020-05-12 Tax Withholding |
2020-05-14 7:00 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Cawkwell Gail SVP, Med Affairs, Safety & PV |
319 | $89.05 | 21,935 (Direct) |
View |
2020-05-08 Tax Withholding |
2020-05-12 7:02 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Ford David A Chief Human Resources Officer |
128 | $87.8 | 13,754 (Direct) |
View |